The hESC-MSC-IMRC-CM-mediated amelioration of pulmonary fibrosis was through a mechanism by suppressing the BLM-induced oxidative stress and inflammation via respective Nox4/Nrf2 and Toll/MyD88 signaling pathways. Here, MYD88 is linked to pulmonary fibrosis.